Antibody-Based Targeting of Cell Surface GRP94 Specifically Inhibits Cetuximab-Resistant Colorectal Cancer Growth. [electronic resource]
Producer: 20200825ISSN:- 2218-273X
- Animals
- Antibodies, Monoclonal, Humanized -- administration & dosage
- Antineoplastic Agents, Immunological -- administration & dosage
- Cell Proliferation -- drug effects
- Cetuximab -- administration & dosage
- Colorectal Neoplasms -- drug therapy
- Drug Resistance, Neoplasm
- HCT116 Cells
- HSP70 Heat-Shock Proteins -- genetics
- Humans
- Membrane Proteins -- genetics
- Mice
- Mice, Inbred BALB C
No physical items for this record
Publication Type: Journal Article; Research Support, Non-U.S. Gov't
There are no comments on this title.
Log in to your account to post a comment.